Alr Technologies Inc (ALRT) 0.0013 $ALRT
ALRT Introduces Value Pricing for Diabetes Management
GlobeNewswire - Tue Dec 22, 8:25AM CST
Medical practices, health insurers, self-insured employers, and other potential users of the ALRT diabetes management system can now choose a pricing plan linked to declines in a patient's A1C level. The plan is designed to eliminate performance risk and to provide rewards for achieving measurable health goals.
ALRT System Significantly Lowers A1C Levels in Type 2 Diabetes Patients in Real World Pilot Program
GlobeNewswire - Tue Nov 17, 8:37AM CST
A 10-month pilot of the ALRT remote monitoring system for diabetes by the Kansas City Metropolitan Physician Association (KCMPA) has found significant improvement in glycemic control for those patients who used the system compared to those who dropped out of the pilot.
Global Remote Patient Monitoring Pipeline Report 2015
M2 - Thu May 14, 6:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/djkt2t/remote_patient) has announced the addition of the "Remote Patient Monitoring - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key remote patient monitoring pipeline products. Scope - Extensive coverage of the Remote Patient Monitoring products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Remote Patient Monitoring and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Remote Patient Monitoring Companies and Product Overview - ActiveCare, Inc. - Agali Technologies, Inc. - AirStrip Technologies, Inc. - ALR Technologies Inc. - Barron Associates, Inc. - BioSensics LLC - Bio-Signal Group Corp. - Boston Scientific Corporation - BrightOutcome Inc. - CellAegis Devices Inc. - autoRIC Device Clinical Trial Details - CorTronix Biomedical Advancement Technologies, Inc. - CurePatch Inc - Dartmouth College - Futura Mobile Health, LLC - Great Lakes NeuroTechnologies - BradyXplore - Guide Analytics Inc. - Ibridge Medical, LLC - JointMetrix Medical, LLC - Kyma Medical Technologies Ltd - OBS Medical Ltd. - PerGenix LLC - Philips Healthcare - Sensogo Ltd. - Sister Kenny Research Center - SPO Global Inc. - The Johns Hopkins University - Thoratec Corporation - Universitat Politecnica de Catalunya - University of New Mexico - University of Toronto - Waldo Health - WANDA Inc - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/dj...te_patient
BSX: 24.17 (+0.21), THOR: 63.50 (+0.05)
ALR Technologies Signs First Revenue-Generating Contract
GlobeNewswire - Mon Apr 20, 7:37AM CDT
ALR Technologies Inc. (OTCQB:ALRT), a leading remote chronic care management and medical device company, is pleased to announce that Clay-Platte Family Medicine Clinic, one of the largest primary care clinics in the Northland of Kansas City, has signed a contract with ALRT to improve diabetes health outcomes using the Health-e-Connect remote chronic care management system.
ALR Technologies Seeks FDA Approval For Insulin Dose Adjustment Feature for Better Diabetes Management
GlobeNewswire - Tue Feb 17, 7:25AM CST
ALR Technologies Inc. (OTCQB: ALRT), a leading remote chronic care management and medical device company, is pleased to announce the submission of a 510(k) application to the U.S. Food and Drug Administration (FDA) for an innovative new addition to the Health-e-Connect system that will help busy physicians avoid common insulin dosing errors and remotely manage large populations of patients with diabetes without sacrificing the quality of care.
Nipro to Partner with ALR Technologies on Chilean Clinical Trial
GlobeNewswire - Tue Jan 20, 7:12AM CST
ALR Technologies Inc. (OTCQB: ALRT) announced that Nipro Diagnostics, Inc. and Nipro Medical Corporation have agreed to participate in a clinical outcomes study to be conducted by ALRT and Hospital Clinico Metropolitano La Florida, one of the largest and most prestigious public hospitals in Santiago, Chile. Nipro will provide its latest blood glucose meter, TRUE METRIX, to all participants in the trial as well as diagnostic supplies such as blood glucose test strips and data management cables. In addition, Nipro employees will assist with subject enrollment and other logistical tasks related to the pilot. Subject enrollment in the pilot is due to begin early next year.
ALRT System May Help Providers Meet Chronic Care Management Reimbursement Requirements
GlobeNewswire - Wed Jan 07, 7:38AM CST
Medical practices may be able to secure new revenue while they improve outcomes for patients with diabetes by using Health-e-Connect, the remote diabetes care management system from ALR Technologies Inc. (OTCQB: ALRT).
ALR Technologies Advocates For Sensible Medicare Reimbursement of Continuous Glucose Monitoring (CGM) for Diabetes Patients
Marketwired - Mon Oct 20, 7:18AM CDT
In a letter to Marilyn Tavenner, Administrator of the Center for Medicare and Medicaid Services (CMS), Bill Smith, President of ALR Technologies (OTCQB: ALRT) advocated for CMS reimbursement for continuous glucose monitoring systems (CGM) for Type 1 diabetes patients as well as higher-risk Type 2 patients. However, Smith argued that most Type 2 patients should first be encouraged to seek Internet-based remote chronic care management and then to step up to CGM if they don't achieve their health goals on the more cost-effective, Internet-based monitoring.
ALR Technologies Enters Latin America with Clinical Trials in Chile
ACCESSWIRE - Tue Oct 14, 7:01AM CDT
Richmond, VA / ACCESSWIRE / October 14, 2014 / ALR Technologies Inc. (OTC: ALRT) has signed an agreement to launch a clinical outcomes study in Chile as a potential solution to the growing number of diabetic patients in Latin America. ALRT's Health-e-Connect is the only off-the-shelf, FDA-cleared system to allow diabetic patients to remotely connect with physicians through a secure website, where Diabetes Care Facilitators (DCFs) regularly monitor the patients' data looking for readings outside of specified parameters.The upcoming trial follows ALRT's first large-scale commercial deployment of the Health-e-Connect system in the United States through the Kansas City Metropolitan Physicians Association in September. The Latin America trial will treat 100 diabetic patients in Santiago, Chile, with a successful trial expected to help establish a presence for ALRT in the large Latin American market.
Health-e-Connect: The FDA-Cleared System at the Forefront of Remote Diabetes Care
ACCESSWIRE - Tue Oct 07, 7:02AM CDT
Richmond, VA / ACCESSWIRE / October 7, 2014 / ALR Technologies' (ALRT) new FDA-cleared Remote Patient Monitoring system may finally allow doctors and clinicians to receive reimbursement for remote chronic care management, and it could become one of the most influential platforms for managing diabetes. ALRT's Health-e-Connect is the only off-the-shelf chronic care system connecting diabetes patients with an experienced care team as well their own physicians - anywhere in the country - through a secure and trusted website. If the Centers for Medicare and Medicaid Services (CMS) proposed payment schedule is finalized on November 1, physicians would receive payments of $41.92 for up to 20 minutes of remote care each month.Implementation of the proposed reimbursement plan would pave the way for ALRT to begin invoicing and collecting revenue for its services for diabetes patients covered by Medicare.Capturing just 1% of the US Medicare market as it pertains to diabetes would represent up to $2.3 million per month in potential revenue to ALRT.
ALRT Introduces Value Pricing for Diabetes Management
GlobeNewswire - Tue Dec 22, 8:25AM CST
Medical practices, health insurers, self-insured employers, and other potential users of the ALRT diabetes management system can now choose a pricing plan linked to declines in a patient's A1C level. The plan is designed to eliminate performance risk and to provide rewards for achieving measurable health goals.
ALRT System Significantly Lowers A1C Levels in Type 2 Diabetes Patients in Real World Pilot Program
GlobeNewswire - Tue Nov 17, 8:37AM CST
A 10-month pilot of the ALRT remote monitoring system for diabetes by the Kansas City Metropolitan Physician Association (KCMPA) has found significant improvement in glycemic control for those patients who used the system compared to those who dropped out of the pilot.
Global Remote Patient Monitoring Pipeline Report 2015
M2 - Thu May 14, 6:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/djkt2t/remote_patient) has announced the addition of the "Remote Patient Monitoring - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key remote patient monitoring pipeline products. Scope - Extensive coverage of the Remote Patient Monitoring products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Remote Patient Monitoring and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Remote Patient Monitoring Companies and Product Overview - ActiveCare, Inc. - Agali Technologies, Inc. - AirStrip Technologies, Inc. - ALR Technologies Inc. - Barron Associates, Inc. - BioSensics LLC - Bio-Signal Group Corp. - Boston Scientific Corporation - BrightOutcome Inc. - CellAegis Devices Inc. - autoRIC Device Clinical Trial Details - CorTronix Biomedical Advancement Technologies, Inc. - CurePatch Inc - Dartmouth College - Futura Mobile Health, LLC - Great Lakes NeuroTechnologies - BradyXplore - Guide Analytics Inc. - Ibridge Medical, LLC - JointMetrix Medical, LLC - Kyma Medical Technologies Ltd - OBS Medical Ltd. - PerGenix LLC - Philips Healthcare - Sensogo Ltd. - Sister Kenny Research Center - SPO Global Inc. - The Johns Hopkins University - Thoratec Corporation - Universitat Politecnica de Catalunya - University of New Mexico - University of Toronto - Waldo Health - WANDA Inc - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/dj...te_patient
BSX: 24.17 (+0.21), THOR: 63.50 (+0.05)
ALR Technologies Signs First Revenue-Generating Contract
GlobeNewswire - Mon Apr 20, 7:37AM CDT
ALR Technologies Inc. (OTCQB:ALRT), a leading remote chronic care management and medical device company, is pleased to announce that Clay-Platte Family Medicine Clinic, one of the largest primary care clinics in the Northland of Kansas City, has signed a contract with ALRT to improve diabetes health outcomes using the Health-e-Connect remote chronic care management system.
ALR Technologies Seeks FDA Approval For Insulin Dose Adjustment Feature for Better Diabetes Management
GlobeNewswire - Tue Feb 17, 7:25AM CST
ALR Technologies Inc. (OTCQB: ALRT), a leading remote chronic care management and medical device company, is pleased to announce the submission of a 510(k) application to the U.S. Food and Drug Administration (FDA) for an innovative new addition to the Health-e-Connect system that will help busy physicians avoid common insulin dosing errors and remotely manage large populations of patients with diabetes without sacrificing the quality of care.
Nipro to Partner with ALR Technologies on Chilean Clinical Trial
GlobeNewswire - Tue Jan 20, 7:12AM CST
ALR Technologies Inc. (OTCQB: ALRT) announced that Nipro Diagnostics, Inc. and Nipro Medical Corporation have agreed to participate in a clinical outcomes study to be conducted by ALRT and Hospital Clinico Metropolitano La Florida, one of the largest and most prestigious public hospitals in Santiago, Chile. Nipro will provide its latest blood glucose meter, TRUE METRIX, to all participants in the trial as well as diagnostic supplies such as blood glucose test strips and data management cables. In addition, Nipro employees will assist with subject enrollment and other logistical tasks related to the pilot. Subject enrollment in the pilot is due to begin early next year.
ALRT System May Help Providers Meet Chronic Care Management Reimbursement Requirements
GlobeNewswire - Wed Jan 07, 7:38AM CST
Medical practices may be able to secure new revenue while they improve outcomes for patients with diabetes by using Health-e-Connect, the remote diabetes care management system from ALR Technologies Inc. (OTCQB: ALRT).
ALR Technologies Advocates For Sensible Medicare Reimbursement of Continuous Glucose Monitoring (CGM) for Diabetes Patients
Marketwired - Mon Oct 20, 7:18AM CDT
In a letter to Marilyn Tavenner, Administrator of the Center for Medicare and Medicaid Services (CMS), Bill Smith, President of ALR Technologies (OTCQB: ALRT) advocated for CMS reimbursement for continuous glucose monitoring systems (CGM) for Type 1 diabetes patients as well as higher-risk Type 2 patients. However, Smith argued that most Type 2 patients should first be encouraged to seek Internet-based remote chronic care management and then to step up to CGM if they don't achieve their health goals on the more cost-effective, Internet-based monitoring.
ALR Technologies Enters Latin America with Clinical Trials in Chile
ACCESSWIRE - Tue Oct 14, 7:01AM CDT
Richmond, VA / ACCESSWIRE / October 14, 2014 / ALR Technologies Inc. (OTC: ALRT) has signed an agreement to launch a clinical outcomes study in Chile as a potential solution to the growing number of diabetic patients in Latin America. ALRT's Health-e-Connect is the only off-the-shelf, FDA-cleared system to allow diabetic patients to remotely connect with physicians through a secure website, where Diabetes Care Facilitators (DCFs) regularly monitor the patients' data looking for readings outside of specified parameters.The upcoming trial follows ALRT's first large-scale commercial deployment of the Health-e-Connect system in the United States through the Kansas City Metropolitan Physicians Association in September. The Latin America trial will treat 100 diabetic patients in Santiago, Chile, with a successful trial expected to help establish a presence for ALRT in the large Latin American market.
Health-e-Connect: The FDA-Cleared System at the Forefront of Remote Diabetes Care
ACCESSWIRE - Tue Oct 07, 7:02AM CDT
Richmond, VA / ACCESSWIRE / October 7, 2014 / ALR Technologies' (ALRT) new FDA-cleared Remote Patient Monitoring system may finally allow doctors and clinicians to receive reimbursement for remote chronic care management, and it could become one of the most influential platforms for managing diabetes. ALRT's Health-e-Connect is the only off-the-shelf chronic care system connecting diabetes patients with an experienced care team as well their own physicians - anywhere in the country - through a secure and trusted website. If the Centers for Medicare and Medicaid Services (CMS) proposed payment schedule is finalized on November 1, physicians would receive payments of $41.92 for up to 20 minutes of remote care each month.Implementation of the proposed reimbursement plan would pave the way for ALRT to begin invoicing and collecting revenue for its services for diabetes patients covered by Medicare.Capturing just 1% of the US Medicare market as it pertains to diabetes would represent up to $2.3 million per month in potential revenue to ALRT.
